Cargando…

Clinicopathological significance of DAPK promoter methylation in non-small-cell lung cancer: a systematic review and meta-analysis

BACKGROUND: Lung carcinogenesis is related to silencing of tumor suppressor genes and activation of oncogenes. The aim was to investigate the significance of death-associated protein kinase (DAPK) methylation in non-small-cell lung cancer (NSCLC) through a meta-analysis. METHODS: A detailed literatu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yan, Wu, Jiang, Huang, Gui, Xu, Shouming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296685/ https://www.ncbi.nlm.nih.gov/pubmed/30588095 http://dx.doi.org/10.2147/CMAR.S174815

Ejemplares similares

Prognostic significance of DAPK promoter methylation in lymphoma: A meta-analysis
por: Wang, Hong, et al.
Publicado: (2019)

Retraction: Prognostic significance of DAPK promoter methylation in lymphoma: A meta-analysis
Publicado: (2023)

Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis
por: Li, Ying, et al.
Publicado: (2015)

DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis
por: Dai, Lihe, et al.
Publicado: (2016)

Clinical effect of DAPK promoter methylation in gastric cancer: A systematic meta-analysis
por: Jia, Wenzhuo, et al.
Publicado: (2016)

Clinicopathological significance of CHFR methylation in non-small cell lung cancer: a systematic review and meta-analysis
por: Wang, Chen, et al.
Publicado: (2017)

Association between promoter methylation of DAPK gene and HNSCC: A meta-analysis
por: Cai, Fucheng, et al.
Publicado: (2017)

Association between DAPK1 Promoter Methylation and Cervical Cancer: A Meta-Analysis
por: Xiong, Jiaqiang, et al.
Publicado: (2014)

DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis
por: Agodi, Antonella, et al.
Publicado: (2015)

Correlation of DAPK1 methylation and the risk of gastrointestinal cancer: A systematic review and meta-analysis
por: Yuan, Wenzheng, et al.
Publicado: (2017)

Diagnostic Value of DAPK Methylation for Nasopharyngeal Carcinoma: Meta-Analysis
por: Lao, Thuan Duc, et al.
Publicado: (2023)

The prognostic significance of DAPK1 in bladder cancer
por: Xie, Jian-Yun, et al.
Publicado: (2017)

Association of Protein Expression and Methylation of DAPK1 with Clinicopathological Features in Invasive Ductal Carcinoma Patients from Kashmir
por: Asiaf, Asia, et al.
Publicado: (2019)

Clinicopathological significance of CXCR4 in non-small cell lung cancer
por: Zhou, Xiao-ming, et al.
Publicado: (2015)

Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis
por: Zhao, Sha, et al.
Publicado: (2016)

Clinicopathological and prognostic significance of Nanog expression in non-small cell lung cancer: a meta-analysis
por: Huang, Guichuan, et al.
Publicado: (2019)

AMPK activates DAPK2 to promote autophagy
por: Shiloh, Ruth, et al.
Publicado: (2018)

Clinicopathological and prognostic significance of SMAD4 in non-small cell lung cancer: A meta-analysis and database validation
por: Li, Zhiqiang, et al.
Publicado: (2023)

Clinicopathological significance of CHFR promoter methylation in gastric cancer: a meta-analysis
por: Ding, Yong, et al.
Publicado: (2017)

Clinicopathological significance of oestrogen receptor expression in non-small cell lung cancer
por: Chen, Xiang-Qi, et al.
Publicado: (2016)

Quantitative and correlation analysis of the DNA methylation and expression of DAPK in breast cancer
por: Zhu, Youzhi, et al.
Publicado: (2017)

Diagnostic potential of methylated DAPK in brushing samples of nasopharyngeal carcinoma
por: Zhang, Jian, et al.
Publicado: (2018)

The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review
por: Yan, Wei, et al.
Publicado: (2016)

Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis
por: Wang, Qingsong, et al.
Publicado: (2020)

Clinicopathological Significance of RUNX1 in Non-Small Cell Lung Cancer
por: Kim, Yujin, et al.
Publicado: (2020)

Prognostic and clinicopathological significance of Beclin-1 in non-small-cell lung cancer: a meta-analysis
por: Zheng, Tianliang, et al.
Publicado: (2018)

Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis
por: Min, Shi-hui, et al.
Publicado: (2021)

Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium
por: Nomura, Tomoe, et al.
Publicado: (2013)

Assessment of DAPK1 and CAVIN3 Gene Promoter Methylation in Breast Invasive Ductal Carcinoma and Metastasis
por: Ghalkhani, Esmat, et al.
Publicado: (2021)

The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review
por: Wu, Xiaoyu, et al.
Publicado: (2016)

Clinicopathological Significance of MTA 1 Expression in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis
por: Zhu, Wei, et al.
Publicado: (2017)

Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer
por: ZHANG, XIE, et al.
Publicado: (2014)

Clinicopathological significance and a potential drugtarget of RARβ in non-small-cell lung carcinoma: a meta-analysis and a systematic review
por: Song, Xiaoyun, et al.
Publicado: (2016)

Clinicopathological significance and prognostic value of E-cadherin expression in non-small cell lung cancer: A protocol for systematic review and meta-analysis
por: Chao, Dong, et al.
Publicado: (2021)

Downregulation of DACT-2 by Promoter Methylation and its Clinicopathological Significance in Prostate Cancer
por: Li, Shibao, et al.
Publicado: (2019)

DANGER is involved in high glucose-induced radioresistance through inhibiting DAPK-mediated anoikis in non-small cell lung cancer
por: Kwon, TaeWoo, et al.
Publicado: (2016)

Expression and Clinicopathological Significance of SOX11 in Small-Cell Lung Cancer
por: Xinli, Wang, et al.
Publicado: (2022)

Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer
por: Ling, Xiao-Ling, et al.
Publicado: (2015)

Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers
por: Liu, Yang, et al.
Publicado: (2007)

Prognostic and Clinicopathological Significance of Downregulated E-Cadherin Expression in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis
por: Yang, Yan-Long, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ols0o0e8ultqsi9og8487lvevf